OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Potential Inhibitor of COVID-19 Main Protease (M<sup>pro</sup>) From Several Medicinal Plant Compounds by Molecular Docking Study
Siti Khaerunnisa, Hendra Kurniawan, Rizki Awaluddin, et al.
(2020)
Open Access | Times Cited: 429
Siti Khaerunnisa, Hendra Kurniawan, Rizki Awaluddin, et al.
(2020)
Open Access | Times Cited: 429
Showing 1-25 of 429 citing articles:
Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
Sukanth Kumar Enmozhi, Kavitha Raja, Irudhayasamy Sebastine, et al.
Journal of Biomolecular Structure and Dynamics (2020), pp. 1-7
Open Access | Times Cited: 388
Sukanth Kumar Enmozhi, Kavitha Raja, Irudhayasamy Sebastine, et al.
Journal of Biomolecular Structure and Dynamics (2020), pp. 1-7
Open Access | Times Cited: 388
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
Sourav Das, Sharat Sarmah, Sona Lyndem, et al.
Journal of Biomolecular Structure and Dynamics (2020), pp. 1-11
Open Access | Times Cited: 335
Sourav Das, Sharat Sarmah, Sona Lyndem, et al.
Journal of Biomolecular Structure and Dynamics (2020), pp. 1-11
Open Access | Times Cited: 335
Could SARS-CoV-2-Induced Hyperinflammation Magnify the Severity of Coronavirus Disease (CoViD-19) Leading to Acute Respiratory Distress Syndrome?
A. S. Smiline Girija, Esaki M. Shankar, Marie Larsson
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 304
A. S. Smiline Girija, Esaki M. Shankar, Marie Larsson
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 304
Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19
M. Mrityunjaya, V. Pavithra, R. Neelam, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 295
M. Mrityunjaya, V. Pavithra, R. Neelam, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 295
Potential effects of curcumin in the treatment of COVID ‐19 infection
Fatemeh Zahedipour, Seyede Atefe Hosseini, Thozhukat Sathyapalan, et al.
Phytotherapy Research (2020) Vol. 34, Iss. 11, pp. 2911-2920
Open Access | Times Cited: 289
Fatemeh Zahedipour, Seyede Atefe Hosseini, Thozhukat Sathyapalan, et al.
Phytotherapy Research (2020) Vol. 34, Iss. 11, pp. 2911-2920
Open Access | Times Cited: 289
A role for quercetin in coronavirus disease 2019 (COVID‐19)
Giuseppe Derosa, Pamela Maffioli, Angela D’Angelo, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 3, pp. 1230-1236
Open Access | Times Cited: 271
Giuseppe Derosa, Pamela Maffioli, Angela D’Angelo, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 3, pp. 1230-1236
Open Access | Times Cited: 271
Statins and the COVID-19 main protease: in silico evidence on direct interaction
Željko Reiner, Mahdi Hatamipour, Maciej Banach, et al.
Archives of Medical Science (2020) Vol. 16, Iss. 3, pp. 490-496
Open Access | Times Cited: 266
Željko Reiner, Mahdi Hatamipour, Maciej Banach, et al.
Archives of Medical Science (2020) Vol. 16, Iss. 3, pp. 490-496
Open Access | Times Cited: 266
Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study
Trina Ekawati Tallei, Sefren Geiner Tumilaar, Nurdjannah J. Niode, et al.
Scientifica (2020) Vol. 2020, pp. 1-18
Open Access | Times Cited: 244
Trina Ekawati Tallei, Sefren Geiner Tumilaar, Nurdjannah J. Niode, et al.
Scientifica (2020) Vol. 2020, pp. 1-18
Open Access | Times Cited: 244
Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review
Susmit Mhatre, Tishya Srivastava, Shivraj Naik, et al.
Phytomedicine (2020) Vol. 85, pp. 153286-153286
Open Access | Times Cited: 240
Susmit Mhatre, Tishya Srivastava, Shivraj Naik, et al.
Phytomedicine (2020) Vol. 85, pp. 153286-153286
Open Access | Times Cited: 240
Naringenin, a flavanone with antiviral and anti‐inflammatory effects: A promising treatment strategy against COVID ‐19
Helda Tutunchi, Fatemeh Naeini, Alireza Ostadrahimi, et al.
Phytotherapy Research (2020) Vol. 34, Iss. 12, pp. 3137-3147
Open Access | Times Cited: 213
Helda Tutunchi, Fatemeh Naeini, Alireza Ostadrahimi, et al.
Phytotherapy Research (2020) Vol. 34, Iss. 12, pp. 3137-3147
Open Access | Times Cited: 213
Natural products' role against COVID-19
Ananda da Silva Antonio, Larissa Silveira Moreira Wiedemann, Valdir Florêncio da Veiga
RSC Advances (2020) Vol. 10, Iss. 39, pp. 23379-23393
Open Access | Times Cited: 209
Ananda da Silva Antonio, Larissa Silveira Moreira Wiedemann, Valdir Florêncio da Veiga
RSC Advances (2020) Vol. 10, Iss. 39, pp. 23379-23393
Open Access | Times Cited: 209
Health Benefits and Chemical Composition of Matcha Green Tea: A Review
Joanna Kochman, Karolina Jakubczyk, Justyna Antoniewicz, et al.
Molecules (2020) Vol. 26, Iss. 1, pp. 85-85
Open Access | Times Cited: 203
Joanna Kochman, Karolina Jakubczyk, Justyna Antoniewicz, et al.
Molecules (2020) Vol. 26, Iss. 1, pp. 85-85
Open Access | Times Cited: 203
Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences
Rohan R. Narkhede, Ashwini V. Pise, Rameshwar S. Cheke, et al.
Natural Products and Bioprospecting (2020) Vol. 10, Iss. 5, pp. 297-306
Open Access | Times Cited: 194
Rohan R. Narkhede, Ashwini V. Pise, Rameshwar S. Cheke, et al.
Natural Products and Bioprospecting (2020) Vol. 10, Iss. 5, pp. 297-306
Open Access | Times Cited: 194
Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches
Anuj Kumar, Gourav Choudhir, Sanjeev Shukla, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 10, pp. 3760-3770
Open Access | Times Cited: 180
Anuj Kumar, Gourav Choudhir, Sanjeev Shukla, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 10, pp. 3760-3770
Open Access | Times Cited: 180
Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target
Umesh, Debanjan Kundu, Chandrabose Selvaraj, et al.
Journal of Biomolecular Structure and Dynamics (2020), pp. 1-9
Open Access | Times Cited: 179
Umesh, Debanjan Kundu, Chandrabose Selvaraj, et al.
Journal of Biomolecular Structure and Dynamics (2020), pp. 1-9
Open Access | Times Cited: 179
Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle
Kanika Khanna, Sukhmeen Kaur Kohli, Ravdeep Kaur, et al.
Phytomedicine (2020) Vol. 85, pp. 153361-153361
Open Access | Times Cited: 176
Kanika Khanna, Sukhmeen Kaur Kohli, Ravdeep Kaur, et al.
Phytomedicine (2020) Vol. 85, pp. 153361-153361
Open Access | Times Cited: 176
Potential SARS-CoV-2 main protease inhibitors
Riddhidev Banerjee, L. Perera, L. M. Viranga Tillekeratne
Drug Discovery Today (2020) Vol. 26, Iss. 3, pp. 804-816
Open Access | Times Cited: 168
Riddhidev Banerjee, L. Perera, L. M. Viranga Tillekeratne
Drug Discovery Today (2020) Vol. 26, Iss. 3, pp. 804-816
Open Access | Times Cited: 168
Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition
Aleix Gimeno, Júlia Mestres‐Truyol, María José Ojeda, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3793-3793
Open Access | Times Cited: 161
Aleix Gimeno, Júlia Mestres‐Truyol, María José Ojeda, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3793-3793
Open Access | Times Cited: 161
Polyphenols and their potential role to fight viral diseases: An overview
María Fernanda Montenegro-Landívar, Paulina Tapia-Quirós, Xanel Vecino, et al.
The Science of The Total Environment (2021) Vol. 801, pp. 149719-149719
Open Access | Times Cited: 151
María Fernanda Montenegro-Landívar, Paulina Tapia-Quirós, Xanel Vecino, et al.
The Science of The Total Environment (2021) Vol. 801, pp. 149719-149719
Open Access | Times Cited: 151
In silico investigation of phytoconstituents from Indian medicinal herb ‘Tinospora cordifolia(giloy)’ against SARS-CoV-2 (COVID-19) by molecular dynamics approach
Papia Chowdhury
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 17, pp. 6792-6809
Open Access | Times Cited: 142
Papia Chowdhury
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 17, pp. 6792-6809
Open Access | Times Cited: 142
Flavonoids are promising safe therapy against COVID-19
Moza Mohamed Alzaabi, Rania Hamdy, Naglaa S. Ashmawy, et al.
Phytochemistry Reviews (2021) Vol. 21, Iss. 1, pp. 291-312
Open Access | Times Cited: 133
Moza Mohamed Alzaabi, Rania Hamdy, Naglaa S. Ashmawy, et al.
Phytochemistry Reviews (2021) Vol. 21, Iss. 1, pp. 291-312
Open Access | Times Cited: 133
Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology
Md. Mominur Rahman, Shabana Bibi, Md. Saidur Rahaman, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113041-113041
Open Access | Times Cited: 113
Md. Mominur Rahman, Shabana Bibi, Md. Saidur Rahaman, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113041-113041
Open Access | Times Cited: 113
An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: A comprehensive review based on up to date knowledge
Doha H. Abou Baker
Toxicology Reports (2022) Vol. 9, pp. 445-469
Open Access | Times Cited: 75
Doha H. Abou Baker
Toxicology Reports (2022) Vol. 9, pp. 445-469
Open Access | Times Cited: 75
Quercetin in the Prevention and Treatment of Coronavirus Infections: A Focus on SARS-CoV-2
Amin Gasmi, Pavan Kumar Mujawdiya, Roman Lysiuk, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1049-1049
Open Access | Times Cited: 71
Amin Gasmi, Pavan Kumar Mujawdiya, Roman Lysiuk, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1049-1049
Open Access | Times Cited: 71
